ProPhase Labs Completes Acquisition of CLIA Accredited Lab and Provides Corporate Update
02. November 2020 08:30 ET
|
ProPhase Labs, Inc.
DOYLESTOWN, Pennsylvania, Nov. 02, 2020 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified medical science and technology company, announced today that it has completed the...
ProPhase Labs Engages Industry Expert to Advise on Possible Acquisition of CLIA Accredited Labs Certified for COVID-19 and Other Testing
30. September 2020 17:04 ET
|
ProPhase Labs, Inc.
Company Enters into Consulting Agreement and Amended and Restated Promissory Note and Security Agreement with Predictive Laboratories, Inc. to Further These Plans DOYLESTOWN, Pennsylvania, Sept. 30,...
ProPhase Labs Announces At-The-Market Equity Facility
23. September 2020 16:10 ET
|
ProPhase Labs, Inc.
DOYLESTOWN, Pennsylvania, Sept. 23, 2020 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH, www.ProPhaseLabs.com) today announced that it has entered into an at-the-market (“ATM”) equity...
PROPHASE LABS, INC. ANNOUNCES SPECIAL CASH DIVIDEND
20. November 2019 16:15 ET
|
ProPhase Labs, Inc.
DOYLESTOWN, PA, Nov. 20, 2019 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH, www.ProPhaseLabs.com), a vertically integrated manufacturer, marketer and distributor of a diversified range of...
ProPhase Labs Reports Financial Results for the Three Months and Nine Months Ended September 30, 2019
12. November 2019 09:35 ET
|
ProPhase Labs, Inc.
DOYLESTOWN, Pennsylvania, Nov. 12, 2019 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH, www.ProPhaseLabs.com) today reported net sales of $2.8 million for the three months ended...